Analyst Ratings for MBX Biosciences Inc (MBX)
MBX Rating Summary
MBX Price Target Summary
- Highest: $88.00 (Guggenheim)
- Lowest: $18.00 (Goldman Sachs)
- Average: $59.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$59.60 (+95.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$59.60 (+95.1%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
66.00 (N/A) |
36.60 (30.55) |
-16.53% | Details |
| 1/7/2026 | UBS » Updated 2/24/2026 |
Michael Yee | New Coverage | Buy (N/A) |
60.00 (60.00) |
29.31 (30.55) |
4.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
